Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AKAN | US
-0.98
-6.27%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
08/06/2026
14.65
15.32
15.42
13.85
Akanda Corp. through its subsidiaries engages in the cultivation manufacture and distribution of cannabis products to patients worldwide. The company operates through Cultivation and Distribution segments. It intends to supply medicinal-grade cannabis and cannabis based medical and wellness products. The company was founded in 2018 and is headquartered in New Romney the United Kingdom.
View LessLow Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
118.6%1 month
281.4%3 months
519.6%6 months
394.5%-
-
0.10
-1.04
0.45
-0.80
3.09
-
-5.73M
41.81M
41.81M
-
-521.92
-
-70.10
-279.79
1.19
2.82
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
11.69
Range1M
18.00
Range3M
78.33
Rel. volume
0.08
Price X volume
619.83K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 0.99 | 45.31M | -2.94% | n/a | 28.90% |
| BioXcel Therapeutics Inc | BTAI | Biotechnology | 1.105 | 45.02M | 0.00% | n/a | -139.46% |
| PEPG | PEPG | Biotechnology | 1.35 | 44.00M | -4.26% | n/a | 12.52% |
| Acrivon Therapeutics Inc. | ACRV | Biotechnology | 1.41 | 43.67M | -1.40% | n/a | 1.95% |
| Entera Bio Ltd | ENTX | Biotechnology | 1.2 | 43.59M | 1.69% | n/a | 3.91% |
| QNCX | QNCX | Biotechnology | 1 | 43.28M | -0.99% | n/a | 30.62% |
| Gain Therapeutics Inc. Common Stock | GANX | Biotechnology | 1.69 | 43.15M | -0.59% | n/a | 6.85% |
| Clene Nanomedicine Inc | CLNN | Biotechnology | 5.33 | 42.44M | -2.20% | n/a | -6472.02% |
| Biomea Fusion Inc. Common Stock | BMEA | Biotechnology | 1.15 | 41.64M | -9.45% | n/a | 9.95% |
| Lantern Pharma Inc. | LTRN | Biotechnology | 3.75 | 40.37M | 4.46% | n/a | 0.71% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Culp Inc | CULP | Textile Manufacturing | 3.09 | 38.60M | -2.22% | n/a | 11.29% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.1 | 16.07M | 7.84% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.4131 | 7.98M | -3.48% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.49 | 3.81M | 12.88% | n/a | 17.32% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.0058 | 534.84K | n/a | -37.05% | |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 0.4181 | 230.37K | 7.87% | n/a | 0.00% |
| Blackstone/GSO Senior Floating Rate Term Fund | BSL | Textile Manufacturing | 12.915 | 0 | 0.19% | n/a |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.80 | 24.85 | Cheaper |
| Ent. to Revenue | 3.09 | 361.91 | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.10 | 13.15 | Cheaper |
| Dividend Yield | - | 2.94 | - |
| Std. Deviation (3M) | 519.61 | 65.24 | Riskier |
| Debt to Equity | -1.04 | -1.88 | Expensive |
| Debt to Assets | 0.45 | 0.48 | Par |
| Market Cap | 41.81M | 3.71B | Emerging |